Jung K - Search Results

1

MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.

Jung M, Mollenkopf HJ, Grimm C, Wagner I, Albrecht M, Waller T, Pilarsky C, Johannsen M, Stephan C, Lehrach H, Nietfeld W, Rudel T, Jung K, Kristiansen G. Jung M, et al. Among authors: jung k. J Cell Mol Med. 2009 Sep;13(9B):3918-28. doi: 10.1111/j.1582-4934.2009.00705.x. Epub 2009 Feb 17. J Cell Mol Med. 2009. PMID: 19228262 Free PMC article.

2

Cystatin C: a promising marker of glomerular filtration rate to replace creatinine.

Jung K, Jung M. Jung K, et al. Among authors: jung m. Nephron. 1995;70(3):370-1. doi: 10.1159/000188621. Nephron. 1995. PMID: 7477630 Free article. No abstract available.

3

Analytical performance and clinical validity of two free prostate-specific antigen assays compared.

Jung K, Stephan C, Lein M, Henke W, Schnorr D, Brux B, Schürenkämper P, Loening SA. Jung K, et al. Clin Chem. 1996 Jul;42(7):1026-33. Clin Chem. 1996. PMID: 8674185

4

Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood.

Henke W, Jung M, Jung K, Lein M, Schlechte H, Berndt C, Rudolph B, Schnorr D, Loening SA. Henke W, et al. Among authors: jung m, jung k. Int J Cancer. 1997 Jan 6;70(1):52-6. doi: 10.1002/(sici)1097-0215(19970106)70:1<52::aid-ijc8>3.0.co;2-5. Int J Cancer. 1997. PMID: 8985090

5

The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia.

Stephan C, Lein M, Jung K, Schnorr D, Loening SA. Stephan C, et al. Among authors: jung k. Cancer. 1997 Jan 1;79(1):104-9. Cancer. 1997. PMID: 8988733

6

Elimination of serum free and total prostate-specific antigen after radical retropubic prostatectomy.

Lein M, Brux B, Jung K, Henke W, Koenig F, Stephan C, Schnorr D, Loening SA. Lein M, et al. Among authors: jung k. Eur J Clin Chem Clin Biochem. 1997 Aug;35(8):591-5. doi: 10.1515/cclm.1997.35.8.591. Eur J Clin Chem Clin Biochem. 1997. PMID: 9298348

7

Relation of free PSA/total PSA in serum for differentiating between patients with prostatic cancer and benign hyperplasia of the prostate: which cutoff should be used?

Lein M, Stephan C, Jung K, Schnorr D, Loening S. Lein M, et al. Among authors: jung k. Cancer Invest. 1998;16(1):45-9. doi: 10.3109/07357909809039753. Cancer Invest. 1998. PMID: 9474251 Review.

8

Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: biochemical and diagnostic implications.

Jung K, Brux B, Lein M, Rudolph B, Kristiansen G, Hauptmann S, Schnorr D, Loening SA, Sinha P. Jung K, et al. Clin Chem. 2000 Jan;46(1):47-54. Clin Chem. 2000. PMID: 10620571

9

Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma.

Lein M, Jung K, Laube C, Hübner T, Winkelmann B, Stephan C, Hauptmann S, Rudolph B, Schnorr D, Loening SA. Lein M, et al. Among authors: jung k. Int J Cancer. 2000 Mar 15;85(6):801-4. doi: 10.1002/(sici)1097-0215(20000315)85:6<801::aid-ijc11>3.0.co;2-c. Int J Cancer. 2000. PMID: 10709099

10

ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: proof of new complex forming of PSA after release into circulation.

Stephan C, Jung K, Brux B, Lein M, Sinha P, Schnorr D, Loening SA. Stephan C, et al. Among authors: jung k. Urology. 2000 Apr;55(4):560-3. doi: 10.1016/s0090-4295(99)00548-8. Urology. 2000. PMID: 10736503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,858 results

Search Page

Filters